These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30194711)

  • 1. Can synthetic urine replace authentic urine to "beat" workplace drug testing?
    Kim VJ; Okano CK; Osborne CR; Frank DM; Meana CT; Castaneto MS
    Drug Test Anal; 2019 Feb; 11(2):331-335. PubMed ID: 30194711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of AdultaCheck 4 test strips for the detection of adulteration at the point of collection of urine specimens used for drugs-of-abuse testing.
    King EJ
    J Anal Toxicol; 1999; 23(1):72. PubMed ID: 10022215
    [No Abstract]   [Full Text] [Related]  

  • 3. Systematic investigations of novel validity parameters in urine drug testing and prevalence of urine adulteration in a two-year cohort.
    Kluge J; Rentzsch L; Remane D; Peters FT; Wissenbach DK
    Drug Test Anal; 2018 Oct; 10(10):1536-1542. PubMed ID: 29956490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adulteration of urine drug testing--an exaggerated cause of concern].
    Beck O; Bohlin M; Bragd F; Bragd J; Greitz O
    Lakartidningen; 2000 Feb; 97(7):703-6. PubMed ID: 10740378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug testing in the workplace.
    Phan HM; Yoshizuka K; Murry DJ; Perry PJ
    Pharmacotherapy; 2012 Jul; 32(7):649-56. PubMed ID: 22605533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine drug screening: can counterfeit urine samples pass inspection?
    Drury DL; Masci V; Jacobson JW; McNutt RA
    J Occup Environ Med; 1999 Aug; 41(8):622-4. PubMed ID: 10457503
    [No Abstract]   [Full Text] [Related]  

  • 7. A new automated assay for the detection of synthetic urine in drug testing.
    Silva F; Kaileh I; Hobbs GA
    Drug Test Anal; 2019 Jul; 11(7):926-930. PubMed ID: 30920168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catching Fakes: New Markers of Urine Sample Validity and Invalidity.
    Goggin MM; Tann CM; Miller A; Nguyen A; Janis GC
    J Anal Toxicol; 2017 Mar; 41(2):121-126. PubMed ID: 27881620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of spot tests with AdultaCheck 6 and Intect 7 urine test strips for detecting the presence of adulterants in urine specimens.
    Dasgupta A; Chughtai O; Hannah C; Davis B; Wells A
    Clin Chim Acta; 2004 Oct; 348(1-2):19-25. PubMed ID: 15369731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine specimen validity test for drug abuse testing in workplace and court settings.
    Lin SY; Lee HH; Lee JF; Chen BH
    J Food Drug Anal; 2018 Jan; 26(1):380-384. PubMed ID: 29389577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Urine Adulterants and Synthetic Urine Samples to Subvert Urine Drug Testing.
    Vikingsson S; Krauss ST; Winecker RE; Flegel RR; Hayes ED
    J Anal Toxicol; 2022 Aug; 46(7):697-704. PubMed ID: 35639619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine pH: the effects of time and temperature after collection.
    Cook JD; Strauss KA; Caplan YH; Lodico CP; Bush DM
    J Anal Toxicol; 2007 Oct; 31(8):486-96. PubMed ID: 17988463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of urine adulterants on commercial drug abuse screening test strip results.
    Rajšić I; Javorac D; Tatović S; Repić A; Đukić-Ćosić D; Đorđević S; Lukić V; Bulat Z
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):87-93. PubMed ID: 32597134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens.
    Tsai LS; ElSohly MA; Tsai SF; Murphy TP; Twarowska B; Salamone SJ
    J Anal Toxicol; 2000; 24(8):708-14. PubMed ID: 11110026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specimen validity testing in urine drug monitoring of medications and illicit drugs: clinical implications.
    Kirsh KL; Christo PJ; Heit H; Steffel K; Passik SD
    J Opioid Manag; 2015; 11(1):53-9. PubMed ID: 25750165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adulterants in Urine Drug Testing.
    Fu S
    Adv Clin Chem; 2016; 76():123-63. PubMed ID: 27645818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and identification of 2-nitro-morphine and 2-nitro-morphine-6-glucuronide in nitrite adulterated urine specimens containing morphine and its glucuronides.
    Luong S; Fu S
    Drug Test Anal; 2014 Mar; 6(3):277-87. PubMed ID: 23592389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Novel Markers for Specimen Validity Testing.
    Kyle PB; Kaur J
    Arch Pathol Lab Med; 2020 Feb; 144(2):168-171. PubMed ID: 31755779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The characterization of human urine for specimen validity determination in workplace drug testing: a review.
    Cook JD; Caplan YH; LoDico CP; Bush DM
    J Anal Toxicol; 2000 Oct; 24(7):579-88. PubMed ID: 11043663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.